Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.27 USD | -3.12% | +3.54% | +3.54% |
Financials (USD)
Sales 2022 | 18.57M | Sales 2023 | 17.47M | Capitalization | 39.45M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -5M | EV / Sales 2022 | 2.91 x |
Net Debt 2022 | 6.69M | Net Debt 2023 | 15.71M | EV / Sales 2023 | 3.16 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-6.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.24% |
Latest transcript on ImmuCell Corporation
1 day | -3.13% | ||
1 week | +3.54% | ||
Current month | +7.33% | ||
1 month | +4.98% | ||
3 months | +4.56% | ||
6 months | +1.35% | ||
Current year | +3.54% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Corporate Officer/Principal | 68 | 16-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
David Tomsche
CHM | Chairman | 67 | 06-12-20 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 5.27 | -3.13% | 23,513 |
24-05-10 | 5.44 | +2.84% | 2,209 |
24-05-09 | 5.29 | +0.76% | 2,308 |
24-05-08 | 5.25 | +2.74% | 21,474 |
24-05-07 | 5.11 | +0.39% | 10,840 |
Delayed Quote Nasdaq, May 13, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+3.54% | 41.23M | |
+29.65% | 48.16B | |
-1.01% | 41.73B | |
+43.34% | 41.03B | |
-5.31% | 28.77B | |
+10.22% | 25.59B | |
-21.21% | 18.96B | |
+6.70% | 12.92B | |
+26.92% | 12.03B | |
-3.10% | 11.77B |
- Stock Market
- Equities
- ICCC Stock